Tarsus Pharmaceuticals, Inc. Common Stock
€52.44
EUR
Last updated on --.
24h volume293.42K
24h highest53.1418 EUR
24h lowest51.8606 EUR
24h Price movement-0.28%
TARS recent prices
24 Hours
-0.28%-€0.1479
30 days
-2.21%-€1.179
60 days
-9.26%-€5.332
90 days
-19.60%-€12.73
Key data
Previous close52.5915 EUR
Market cap2.40B EUR
Volume293.42K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.97169 EUR
Net income (FY)-41.50M EUR
Revenue (FY)460.11M EUR
Last report dateMay 6, 2026
About Tarsus Pharmaceuticals, Inc. Common Stock
HeadquartersIRVINE
Employees (FY)370.00
Revenue per employee (FY)1.24M EUR
Net income per employee (FY)-112.17K EUR
Listed onNasdaq
TARS conversion tables
 |  |
|---|---|
| 0.5 TARS | 26.22 EUR |
| 1 TARS | 52.44 EUR |
| 5 TARS | 262.21 EUR |
| 10 TARS | 524.43 EUR |
| |
|---|---|
| 0.5 EUR | 0.0095341 TARS |
| 1 EUR | 0.019068 TARS |
| 5 EUR | 0.095341 TARS |
| 10 EUR | 0.19068 TARS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TARS is trading at €52.44, -0.28% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TARS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TARS is currently trading at €52.44, -0.28% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TARS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TARS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TARS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TARS's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Tarsus Pharmaceuticals, Inc. Common Stock's market cap is currently 2.40B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume293.42K
24h highest53.1418 EUR
24h lowest51.8606 EUR
24h Price movement-0.28%
Start trade with TARS Perpetual
Sign up to trade